PGIM India Healthcare Fund Review – PGIM India Healthcare Fund Review Direct NFO Open on 19 November 2024 and Close on 03 December 2024. PGIM India Healthcare Fund Direct NFO Allotment Date is 06 December 2024, and the NFO Type is Open-Ended. NFO Riskometer is Very High Risk, and the Minimum Investment Amount is ₹5,000. The Minimum SIP Investment Amount is ₹1,000.
Type of the Scheme
An open ended equity scheme investing in healthcare and pharmaceutical sector.
Scheme Benchmark : BSE Healthcare TRI – As required under clause 1.9 of Master Circular , the benchmark has been selected from amongst those notified by AMFI as the first tier
benchmark to be adopted by mutual funds and which are reflective of the category of the scheme.
PGIM India Healthcare Fund Scheme Benchmark
| Company | Sector |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES | Healthcare |
| CIPLA LTD. | Healthcare |
| DR.REDDYS LABORATORIES LTD. | Healthcare |
| DIVIS LABORATORIES LTD. | Healthcare |
| Max Healthcare Institute Limit | Healthcare |
| APOLLO HOSPITALS ENTERPRISE LT | Healthcare |
| LUPIN LTD. | Healthcare |
| AUROBINDO PHARMA LTD. | Healthcare |
| FORTIS HEALTHCARE LTD. | Healthcare |
| Alkem Laboratories Limited | Healthcare |
PGIM India Healthcare Fund Important Date
| Scheme Offer | PGIM India Healthcare Fund |
|---|---|
| Offer Price | Rs. 10/- per Unit |
| Type of Scheme | An open-ended |
| Open Date | 19 Nov 2024 |
| Close Date | 03 Dec 2024 |
| Allotment Date | 06 Dec 2024 |
| Category | Sectoral Fund |
| Min Inv ₹ | ₹5,000 |
| Lock in Period | N/A |
| Risk | Very High |
| Scheme Benchmark | BSE Healthcare TRI |
Investment Objective of the Scheme ?
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns.
PGIM India Healthcare Fund Other Details
| Exit Load | 0.50% |
|---|---|
| Exit Load Details | Exit load of 0.50%, if redeemed within 90 days. |
| Entry Load | N/A |
| Stamp Duty | 0.005% |
| Min. Investment | Rs. 5,000 |
| Min. SIP | Rs. 1,000 |
PGIM India Healthcare Fund Asset Allocation
| Instruments | Allocation Min | Allocation Max |
|---|---|---|
| Equity and equity related securities of pharmaceutical and healthcare companies | 80% | 100% |
| Equity and Equity related securities of other Companies | 0% | 20% |
| Debt and Money Market Securities (including TREPS (Tri-Party Repo), Reverse Repo) | 0% | 20% |
| Units issued by REITs & InvITs | 0% | 10% |
| Foreign securities including overseas ETFs | 0% | 20% |
Manager Manage the Scheme?
Fund Manger : Mr. Anandha Padmanabhan Anjeneya
Qualification : B. Com, ACA, CFA, FRM
Experience : Collectively over 15 years of experience in Indian financial markets, primarily in equity research.
Fund Manger : Mr. Utsav Mehta
Qualification : B.Com., CFA
Experience : Over 13 years of experience in Equity market, research and fund management.
Fund Manger : Mr. Vivek Sharma
Qualification : PGDM – Finance
Experience : Over 14 years of experience in Equity market, research and fund management.
Fund Manger : Mr. Puneet Pal
Qualification : MBA (Finance) from Symbiosis Institute of Business Management, Pune
Experience : More than 20 years of experience in the Debt markets within the Mutual Fund space. Below are details on his past stints.
PGIM India Healthcare Fund Index Return
| Index Return | QTD | YTD | 1 Year | 5 Years | 10 Years |
|---|---|---|---|---|---|
| Price Return | 8.38% | 39.20% | 61.03% | 27.12% | 11.83% |
| Total Return | 8.56% | 39.93% | 61.91% | 27.95% | 12.53% |
Where Will the Scheme Invest ?
- Indian Equity and equity related securities including convertible bonds and debentures and warrants carrying the right to obtain equity shares.
- Securities created and issued by the Central and State Governments and/or repos/reverse repos in such Government Securities as may be permitted by RBI (including but not limited to coupon bearing bonds, zero coupon bonds and treasury bills).
- Securities guaranteed by the Central and State Governments (including but not limited to coupon bearing bonds, zero coupon bonds and treasury bills).
- Repos of Corporate debt securities.
- Debt securities issued by domestic Government agencies and statutory bodies, which may or may not carry a Central/State Government guarantee. Corporate debt securities (of both public and private sector undertakings).
- Securities issued by banks (both public and private sector) as permitted by SEBI from time to time and development financial institutions.
- Money market instruments permitted by RBI/SEBI, having maturities of up to one year, or in alternative investment for the call money market.
- Certificate of Deposits (CDs).
- Tri -Party Repo (TREPS).
- Commercial Paper (CPs).
- The non-convertible part of convertible securities.
- Securitised Debt, Debt instruments having structured obligations / credit enhancements.
- Investment in units of Real Estate Investment Trust (‘REIT’) & Infrastructure Investment Trust (‘InvIT’).
- Derivative instruments like, Stock / Index Futures, Stock / Index Options and such other derivative instruments permitted by SEBI.
- Cash & cash equivalents.
- Foreign securities as defined under Paragraph 12.19 of SEBI master circular . The Investment in Foreign Securities shall be in accordance with the guidelines issued by SEBI and RBI from time to time.
- Schemes managed by the AMC or the schemes launched by SEBI registered Mutual Funds, provided it is in conformity to the investment objectives of the Scheme and in terms of the prevailing Regulations.
Also Read: Shriram Multi Sector Rotation Fund Review
PGIM India Healthcare Fund Registrar
KFIN TECHNOLOGIES LIMITED
Selenium Tower- B, Plot 31-32, Gachibowli, Financial
District, Nanakramguda, Serilingampally, Hyderabad500 032, Telangana, India.
Tel No.: +91 40 6716 2222
Website: Www.Kfintech.Com
Email: Hoacfoods.Ipo@Kfintech.Com
Investor Grievance Email:Einward.Ris@Kfintech.Com
Contact Person: Mr. M Murali Krishna
6 thoughts on “PGIM India Healthcare Fund Review – Regular Plan”